For decades, eggs have lived a strange double life in nutrition science. Once vilified as a driver of heart disease, they are now often celebrated as a “superfood.” So which is it?

The answer lies in a deeper understanding of cholesterol—one that has evolved significantly in recent years. Modern research has moved beyond simplistic ideas and now paints a more nuanced picture: dietary cholesterol is not the main culprit—but blood lipoproteins still matter a great deal.

Cholesterol Is Not the Villain We Thought

Cholesterol is essential for life. It builds cell membranes, serves as a precursor for hormones, and is required for vitamin D synthesis. Your body produces most of its cholesterol in the liver and carefully regulates levels.

This explains why dietary cholesterol, such as that found in eggs, usually has a modest effect on blood cholesterol levels in most people. But this is only part of the story.

The Real Issue: Lipoproteins and Arterial Biology

Cholesterol does not float freely in the blood. It is transported inside particles called lipoproteins—most importantly LDL (low-density lipoprotein).

Each LDL particle carries cholesterol, but more importantly:

Each LDL particle (via its apoB protein) is a potential initiator of atherosclerosis.

The key insight from modern cardiovascular science is that it is the number of these particles—apoB—that drives risk, not just the amount of cholesterol they carry.

How Atherosclerosis Actually Begins

To understand why this matters, we need to look at what happens at the level of the arterial wall.

Atherosclerosis is not a sudden event—it is a slow, cumulative biological process that can begin decades before symptoms appear.

It unfolds roughly like this:

1. LDL particles circulate in the bloodstream
2. They cross the endothelial barrier (the inner lining of arteries)
3. They become trapped in the arterial wall
4. They are chemically modified (e.g., oxidized)
5. The immune system reacts → inflammation develops
6. Plaque forms and gradually grows

But why do LDL particles enter the artery wall in the first place?

Why LDL Enters the Arterial Wall

The endothelium—the thin layer of cells lining blood vessels—is not completely impermeable. It allows the exchange of molecules between blood and tissue.

LDL particles can cross this barrier through:

• Passive diffusion (especially in areas of disturbed blood flow)
• Active transport mechanisms

Importantly, certain regions of the vascular system—such as branch points and curves—experience turbulent or low shear stress blood flow. These areas make the endothelium more permeable and biologically “activated.”

This is why plaques tend to form in predictable locations, such as:

• coronary artery branches
• carotid bifurcations

Why LDL Gets Stuck

Once LDL particles enter the arterial wall, they do not always leave.

They can bind to molecules in the extracellular matrix, particularly proteoglycans—large, negatively charged structures in the vessel wall.

This interaction is key:

• apoB on LDL has regions that bind strongly to proteoglycans
• this causes LDL to become retained in the arterial wall

This “retention” is now considered a central initiating event in atherosclerosis.

Without retention, LDL would simply pass in and out without consequence.

Why LDL Becomes Dangerous

Once trapped, LDL particles are more likely to undergo chemical changes:

• Oxidation
• Glycation
• Other structural modifications

These modified particles are no longer recognized as “normal” by the body.

They trigger an immune response:

• immune cells (monocytes) enter the vessel wall
• they transform into macrophages
• they engulf modified LDL → becoming foam cells

This leads to:

• local inflammation
• fatty streaks (early plaque)
• progressive plaque growth

A Disease of Exposure: Dose × Time

This entire process depends on two key variables:

👉 How many particles are present (apoB)
👉 How long they circulate

This is why cardiovascular risk is often described as a function of:

cumulative exposure to apoB-containing particles over time

• More particles → higher probability of arterial entry and retention
• Longer exposure → more accumulation and damage

Even small differences in LDL/apoB, sustained over decades, can have large effects on lifetime risk.

Where Diet—and Eggs—Fit Into This

This mechanistic understanding helps resolve the apparent paradox around eggs.

Eggs contain cholesterol—but:

• dietary cholesterol has limited impact on apoB in most people
• therefore, eggs often have little effect on this underlying disease process

However:

• if a diet (including high egg intake) raises apoB/LDL,
• then it can increase the rate of particle entry and retention in arteries

The food itself is not the issue—the biological response is.

The Bigger Picture

Modern cardiovascular science no longer asks: “Does this food contain cholesterol?”

Instead, it asks: “How does this dietary pattern affect apoB-containing lipoproteins—and for how long?”

This shift explains why:

• eggs can be part of a healthy diet
• but extremely high intake may not be risk-free for everyone

What Determines the Number of ApoB Particles?

If apoB-containing lipoproteins are the true drivers of atherosclerosis, a natural question follows:

What actually determines how many of these particles we have?

The answer lies primarily in the liver, which controls both the production and removal of these particles.

The Liver as the Central Regulator

ApoB-containing particles (VLDL, which later become LDL) are produced in the liver. Their number in circulation depends on two opposing processes:

• Production: how many particles the liver releases
• Clearance: how efficiently they are removed from the blood

An increase in apoB can result from:

• higher production
• reduced clearance
• or both

Production: When the Liver Sends Out More Particles

The liver increases production of apoB-containing particles when it is metabolically overloaded—particularly when it accumulates fat.

This tends to occur under conditions such as:

• excess calorie intake
• insulin resistance
• fatty liver (hepatic steatosis)

In these states, the liver packages excess fat into VLDL particles and releases them into circulation.

More liver fat → more VLDL → more LDL → higher apoB

Clearance: The Role of LDL Receptors

ApoB particles are removed from the bloodstream primarily via LDL receptors in the liver.

When these receptors function efficiently:

• LDL particles are cleared quickly
• apoB levels decrease

When receptor activity is reduced:

• particles remain in circulation longer
• apoB levels rise

This mechanism is central to understanding how diet affects cardiovascular risk.

Diet and ApoB: What Matters Most?

Not all dietary factors influence apoB equally. Some have strong and consistent effects, while others are more variable.

Saturated Fat: A Key Driver

Saturated fat has one of the most consistent effects on apoB levels.

It tends to:

• reduce LDL receptor activity
• impair clearance of LDL particles

As a result:

Higher intake of saturated fat often leads to higher apoB levels

Common sources include:

• butter
• fatty cuts of meat
• cream
• certain cheeses

Excess Calories and Weight Gain

A sustained calorie surplus—regardless of macronutrient source—can increase apoB.

This is especially true when it leads to:

• visceral fat accumulation
• insulin resistance
• fatty liver

These conditions stimulate VLDL production in the liver, increasing the number of circulating particles.

Refined Carbohydrates and Sugar

Refined carbohydrates do not directly raise apoB in the same way saturated fat does, but they can contribute indirectly.

High intake of:

• sugar
• refined grains
• ultra-processed foods

can promote insulin resistance and liver fat accumulation, which in turn:
→ increases VLDL production
→ raises apoB

Dietary Cholesterol and Eggs

In contrast, dietary cholesterol—such as that found in eggs—generally has a smaller and more variable effect on apoB.

For most individuals:

• egg consumption has little impact on apoB levels

However:

• some individuals experience increases
• higher intakes increase the likelihood of a measurable effect

This reinforces a key point:

The impact of a food depends on the body’s response—not just its composition.

What Helps Lower ApoB?

Several dietary and lifestyle factors consistently reduce apoB levels:

• Unsaturated fats (e.g., olive oil, nuts, fatty fish)
  → improve LDL receptor activity
• Soluble fiber (e.g., oats, legumes)
  → enhances cholesterol clearance
• Weight loss (if overweight)
  → reduces liver fat and VLDL production
• Physical activity
  → improves metabolic health and lipid handling

A System, Not a Single Nutrient

The key insight is that apoB is not controlled by a single food or nutrient, but by the metabolic state of the liver.

Two individuals can eat similar diets yet have very different apoB levels depending on:

• body composition
• insulin sensitivity
• genetics
• physical activity

A Simple Mental Model

A useful way to think about this is:

• ApoB = number of “vehicles” in the bloodstream
• LDL cholesterol = how much cargo each vehicle carries

Cardiovascular risk is driven primarily by the number of vehicles—not just their size.

The Takeaway

• ApoB reflects the number of atherogenic particles, not just cholesterol levels
• It is influenced primarily by liver metabolism and receptor function
• Saturated fat, excess calories, and metabolic dysfunction tend to increase apoB
• Dietary cholesterol plays a smaller and more individual role

Understanding this helps explain why modern nutrition science has shifted focus—from single nutrients like cholesterol to the broader regulation of lipoprotein particles over time.

The Bottom Line

Cholesterol itself is not the enemy—it is an essential molecule the body tightly regulates.

What matters is not how much cholesterol you eat, but how many apoB-containing lipoprotein particles circulate in your blood, and for how long. These particles drive atherosclerosis by entering and becoming trapped in the arterial wall, initiating a slow, cumulative process of plaque formation.

Dietary cholesterol plays a relatively minor and highly individual role in this system. By contrast, factors that influence particle number—such as saturated fat intake, metabolic health, and liver function—are far more important.

Eggs, despite their cholesterol content, are generally safe and nutritionally valuable when consumed in moderation. Their impact depends less on the egg itself and more on the broader metabolic context in which they are eaten.

Ultimately, cardiovascular disease is not caused by a single food, but by long-term exposure to apoB-containing particles interacting with the arterial wall over time.

References

Core Mechanism: ApoB, LDL, and Atherosclerosis

1. Ference BA et al. (2017) Low-density lipoproteins cause atherosclerotic cardiovascular disease
   Comprehensive consensus paper demonstrating causal role of LDL/apoB in atherosclerosis using genetics, epidemiology, and trials.
2. Borén J et al. (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights
   Mechanistic deep dive into LDL retention, proteoglycan binding, and plaque initiation.
3. Tabas I et al. (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis
   Landmark paper describing the “response-to-retention” hypothesis.
4. Williams KJ & Tabas I (1995) The response-to-retention hypothesis of early atherogenesis
   Foundational model explaining why LDL gets trapped in the arterial wall.

ApoB vs LDL-C (Particle Number vs Cholesterol Content)

5. Sniderman AD et al. (2019) Apolipoprotein B particles and cardiovascular disease
   Shows that apoB (particle number) is a better risk predictor than LDL-C.
6. Ference BA et al. (2012) Mendelian randomization analysis of LDL cholesterol and cardiovascular disease
   Demonstrates that lifelong exposure to lower LDL reduces risk dramatically.

Dietary Cholesterol and Eggs

7. Berger S et al. (2015) Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis
   Finds no clear association between dietary cholesterol and CVD in general populations.
8. Rong Y et al. (2013) Egg consumption and risk of coronary heart disease and stroke
   Large meta-analysis showing no increased CVD risk with moderate egg intake.
9. Drouin-Chartier JP et al. (2020) Egg consumption and risk of cardiovascular disease
   Updated analysis supporting neutral effects of eggs in most individuals.
10. Griffin BA et al. (2023) Eggs and cardiovascular health: a review
    Highlights individual variability and context-dependent effects.

Randomized Trials: Eggs and Blood Lipids

11. Bergeron N et al. (2016) Egg consumption and lipid profiles in healthy individuals
    Shows modest increases in LDL and HDL with higher egg intake.
12. Fuller NR et al. (2015) Effect of a high-egg diet on cardiovascular risk markers
    Indicates no adverse effects in the context of a healthy diet.

Saturated Fat and Lipoproteins

13. Mensink RP (2016) Effects of saturated fatty acids on serum lipids
    Demonstrates that saturated fat raises LDL consistently.
14. Siri-Tarino PW et al. (2010) Meta-analysis of saturated fat and cardiovascular disease
    Highlights complexity but does not negate LDL-raising effect of saturated fat.

Lipid Lowering and Causality (Clinical Trials)

15. Sabatine MS et al. (2017) Evolocumab and clinical outcomes in cardiovascular disease
    PCSK9 inhibitor trial showing LDL reduction → reduced events.
16. Cholesterol Treatment Trialists’ Collaboration (2010) Efficacy of statins
    Large meta-analysis confirming dose-dependent risk reduction with LDL lowering.

Guidelines and Consensus Reports

17. American Heart Association (AHA) dietary guidelines
    Current stance: moderate egg intake acceptable; focus on overall diet quality.
18. Nordic Nutrition Recommendations 2023 (NNR 2023)
    Concludes up to ~1 egg/day not associated with increased CVD risk, but limited data at higher intakes.

Summary of Evidence Base

This body of evidence supports a more refined and mechanistic understanding of cardiovascular risk:

• ApoB-containing lipoproteins are causally linked to atherosclerosis, with particle number (apoB) determining the probability of arterial entry, retention, and plaque formation over time
• Atherosclerosis is initiated by the retention of these particles in the arterial wall, followed by modification and immune activation—making it a cumulative “dose × time” process
• Dietary cholesterol has a limited and highly variable effect on apoB levels, as endogenous regulation compensates in most individuals
• Eggs are nutrient-dense and generally neutral with respect to cardiovascular risk in moderate amounts, with effects largely dependent on individual lipid responses
• Saturated fat has a more consistent impact on apoB, primarily by reducing LDL receptor activity and impairing particle clearance
• Metabolic factors—such as liver fat, insulin resistance, and energy balance—play a central role in determining apoB production and overall particle burden
• Individual variability is substantial, meaning that the same dietary pattern can produce very different apoB responses across individuals